I agree that this site is using cookies. You can find further informations here.
X
Nishina, Tomohiro
206  results:
Search for persons X
?
1

Clinical features associated with NeoRAS wild-type metastat..:

Osumi, Hiroki ; Shinozaki, Eiji ; Nakamura, Yoshiaki...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Trastuzumab deruxtecan in HER2-positive advanced gastric ca..:

Shitara, Kohei ; Bang, Yung-Jue ; Iwasa, Satoru...
Nature Medicine.  30 (2024)  7 - p. 1933-1942 , 2024
Link: https://doi.org/10.1038/..
 
?
3

Plasma Angiogenic Factors as Predictors of the Efficacy of ..:

Yuki, Satoshi ; Yamazaki, Kentaro ; Sunakawa, Yu...
Clinical Colorectal Cancer.  23 (2024)  2 - p. 147-159.e7 , 2024
Link: https://doi.org/10.1016/..
 
?
4

The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Qu..:

Hashimoto, Tadayoshi ; Nakamura, Yoshiaki ; Fujisawa, Takao...
Cancer Discovery.  , 2024
Link: https://doi.org/10.1158/..
 
?
5

Different efficacy of tyrosine kinase inhibitors by KIT and..:

Hashimoto, Tadayoshi ; Nakamura, Yoshiaki ; Komatsu, Yoshito...
BJC Reports.  2 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
6

First-line pembrolizumab plus chemotherapy for advanced/met..:

Kato, Ken ; Kojima, Takashi ; Hara, Hiroki...
Esophagus.  21 (2024)  3 - p. 306-318 , 2024
Link: https://doi.org/10.1007/..
 
?
7

Efficacy of Pembrolizumab Monotherapy in Japanese Patients ..:

Muro, Kei ; Shitara, Kohei ; Yamaguchi, Kensei...
Journal of Gastrointestinal Cancer.  54 (2023)  3 - p. 951-961 , 2023
Link: https://doi.org/10.1007/..
 
?
8

Mutational spectrum of TP53 gene correlates with nivolumab ..:

Ando, Koji ; Nakamura, Yoshiaki ; Kitao, Hiroyuki...
British Journal of Cancer.  129 (2023)  6 - p. 1032-1039 , 2023
Link: https://doi.org/10.1038/..
 
?
9

Validity and utility of blood tumor mutational burden (bTMB..:

Mishima, Saori ; Nakamura, Yoshiaki ; Tukachinsky, Hanna...
The Journal of Liquid Biopsy.  1 (2023)  - p. 100003 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Regulation of MEK inhibitor selumetinib sensitivity by AKT ..:

Nakai, Chikako ; Mimaki, Sachiyo ; Matsushima, Koutatsu...
International Journal of Clinical Oncology.  28 (2023)  5 - p. 654-663 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Final results of DESTINY-CRC01 investigating trastuzumab de..:

Yoshino, Takayuki ; Di Bartolomeo, Maria ; Raghav, Kanwal...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
12

Role of plasma angiogenesis factors in the efficacy of firs..:

Yuki, Satoshi ; Yamazaki, Kentaro ; Sunakawa, Yu...
Cancer Medicine.  12 (2023)  18 - p. 18702-18716 , 2023
Link: https://doi.org/10.1002/..
 
?
13

Sidedness-Dependent Prognostic Impact of Gene Alterations i..:

Kajiwara, Takeshi ; Nishina, Tomohiro ; Yamashita, Riu...
Cancers.  15 (2023)  21 - p. 5172 , 2023
Link: https://doi.org/10.3390/..
 
?
14

Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Pati..:

Kito, Yosuke ; Kawakami, Hisato ; Mitani, Seiichiro...
The Oncologist.  29 (2023)  3 - p. e330-e336 , 2023
Link: https://doi.org/10.1093/..
 
?
15

An exploration of trifluridine/tipiracil in combination wit..:

Mizukami, Takuro ; Minashi, Keiko ; Hara, Hiroki...
Investigational New Drugs.  40 (2022)  3 - p. 614-621 , 2022
Link: https://doi.org/10.1007/..
 
1-15